BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22188115)

  • 1. Management of children with high-risk Hodgkin lymphoma.
    Kelly KM
    Br J Haematol; 2012 Apr; 157(1):3-13. PubMed ID: 22188115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.
    Giulino-Roth L; Keller FG; Hodgson DC; Kelly KM
    Br J Haematol; 2015 Jun; 169(5):647-60. PubMed ID: 25824371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin lymphoma in Tyrol-a population-based study.
    Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
    Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
    Picardi M; Pugliese N; Cirillo M; Zeppa P; Cozzolino I; Ciancia G; Pettinato G; Salvatore C; Quintarelli C; Pane F
    Radiology; 2014 Jul; 272(1):262-74. PubMed ID: 24708193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin lymphoma in children and adolescents: improving the therapeutic index.
    Kelly KM
    Hematology Am Soc Hematol Educ Program; 2015; 2015():514-21. PubMed ID: 26637767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease.
    Evens AM; Kostakoglu L
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):135-43. PubMed ID: 25696846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).
    Gorde-Grosjean S; Oberlin O; Leblanc T; Pacquement H; Donadieu J; Lambilliotte A; Schell M; Dommange F; Munzer M; Paillard C; Schmitt C; Lutz P; Edan C; Ansoborlo S; Stephan JL; Michel G; Thomas C; Perel Y; Robert A; Landman-Parker J
    Br J Haematol; 2012 Sep; 158(5):649-56. PubMed ID: 22757721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics of 34 children with Hodgkin lymphoma and efficacy of treatment with chemotherapy plus low dose radiotherapy on involved sites].
    Duan YL; Zhang YH; Jin L; Yang J; Zhang R; Zhou CJ
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):698-702. PubMed ID: 21092533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.
    Dann EJ; Berkahn L; Mashiach T; Frumer M; Agur A; McDiarmid B; Bar-Shalom R; Paltiel O; Goldschmidt N
    Br J Haematol; 2014 Mar; 164(5):694-700. PubMed ID: 24313286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2014 Jul; 89(7):771-9. PubMed ID: 24953862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of Hodgkin's lymphoma (HL) in children].
    Kolygin BA
    Vopr Onkol; 2002; 48(3):269-73. PubMed ID: 12455347
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma.
    Araf S; Montoto S
    Future Oncol; 2013 Jun; 9(6):807-15. PubMed ID: 23718301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in Hodgkin lymphoma.
    Josting A
    Expert Rev Hematol; 2010 Oct; 3(5):583-92. PubMed ID: 21083475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
    Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern treatment of Hodgkin lymphoma.
    Bartlett NL
    Curr Opin Hematol; 2008 Jul; 15(4):408-14. PubMed ID: 18536581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of early response assessment in lymphoma with FDG-PET.
    MacManus MP; Seymour JF; Hicks RJ
    Cancer Imaging; 2007; 7(1):10-8. PubMed ID: 17766210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.
    Jabbour E; Hosing C; Ayers G; Nunez R; Anderlini P; Pro B; Khouri I; Younes A; Hagemeister F; Kwak L; Fayad L
    Cancer; 2007 Jun; 109(12):2481-9. PubMed ID: 17497648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the initial management of Hodgkin's Lymphoma.
    Marri PR; Ansell SM
    Transfus Apher Sci; 2013 Aug; 49(1):12-8. PubMed ID: 23769695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing relapsed and refractory Hodgkin lymphoma.
    Brice P
    Br J Haematol; 2008 Apr; 141(1):3-13. PubMed ID: 18279457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.